You have 9 free searches left this month | for more free features.

lenalidomide

Showing 1 - 25 of 571

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large-cell B-cell Lymphoma Trial in Seattle (plamotamab, tafasitamab, lenalidomide)

Recruiting
  • Diffuse Large-cell B-cell Lymphoma
  • plamotamab
  • +2 more
  • Seattle, Washington
    Swedish Cancer Center
May 2, 2022

Dermatomyositis Trial in Nanchang (Lenalidomide)

Not yet recruiting
  • Dermatomyositis
  • Lenalidomide
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Aug 3, 2022

Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Cologne, Germany
    University of Cologne
Oct 14, 2022

CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Zanubrutinib, Lenalidomide, Zanubrutinib, Lenalidomide)

Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 16, 2021

Multiple Myeloma Trial (Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 19, 2022

Multiple Myeloma Trial in Busan (Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

Recruiting
  • CNS Lymphoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 10, 2022

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Smouldering Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Lenalidomide)

Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
Mar 22, 2022

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +13 more
Feb 7, 2022

Acute Myeloid Leukemia Trial in Chapel Hill (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Lenalidomide
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill - Lineberger Compreh
Jan 25, 2022

Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Lenalidomide
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 11, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Nov 29, 2022

Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 12, 2022

Multiple Myeloma Trial in Aurora, New York (Clarithromycin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
Feb 1, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Lenalidomide
  • Sacramento, California
    University of California Davis
Mar 8, 2022

DLBCL Trial (PF-07901801, Tafasitamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Nov 15, 2022

CNS Lymphoma Trial in Seongnam-si (lenalidomide)

Recruiting
  • Central Nervous System Lymphoma
  • lenalidomide
  • Seongnam-si, Please Select, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 18, 2022

Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
Dec 23, 2021

Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • lenalidomide
  • rituximab
  • Tampa, Florida
  • +3 more
Mar 26, 2022

Multiple Myeloma Trial in Beijing (Ixazomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    PekingUMCH
Nov 30, 2021